Back
HFA Premium Access

Tolvaptan is useful and safe for the treatment of very elderly patients with heart failure and chronic kidney disease

Session: Poster Session 1 - Chronic heart failure
Topic: Chronic nursing care
Speaker: Doctor K. Yoshioka (Osaka, JP)
Event: HEART FAILURE 2016

Congress Presentation

Add to my library

Like

About the speaker

Doctor Kei Yoshioka

Kansai Medical University Medical Center, Osaka (Japan)
0 follower

48 more presentations in this session

The role and importance of interleukin investigation in chronic heart failure

Speaker: Doctor M. Juraev (Tashkent, UZ)

Access
Abstract
Like
Thumbnail

Impaired gas diffusion and RV to pulmonary circulation uncoupling limit exercise performance in heart failure patients

Speaker: Doctor V. Labate (San Donato Milanese, IT)

Access
Abstract
Like
Thumbnail

Study of the effect of lisinopril on the kidney functional state in the patients with chronic heart failure

Speaker: Professor Z. Rasulova (Tashkent, UZ)

Access
Abstract
Like
Thumbnail

Risk stratification of ambulatory patients with chronic heart failure by six-minute walking test and B-type natriuretic peptide: results from the nebula network study group

Access
Like
Thumbnail

17beta-estradiol reduces endothelin-1 release in women with ischaemic left ventricular dysfunction

Speaker: Professor G. Rosano (London, GB)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 1 - Chronic heart failure

Speakers: Doctor K. Yoshioka, Doctor M. Juraev, Doctor V. Labate, Professor Z. Rasulova, Professor G. Rosano
Access
Like
Thumbnail

About the event

Image

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources